Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells

BACKGROUND/AIMS: Balsalazide is an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide can reduce inflammatory responses via several mechanisms, including inhibition of nuclear factor-κB (NF-κB) activity. Parthenolide (PT) inhibits NF-κB and exerts promising antic...

Full description

Saved in:
Bibliographic Details
Published in:Intest Res
Main Authors: Kim, Hyun-Young, Kim, Se-Lim, Park, Young-Ran, Liu, Yu-Chuan, Seo, Seung Young, Kim, Seong Hun, Kim, In Hee, Lee, Seung Ok, Lee, Soo Teik, Kim, Sang Wook
Format: Artigo
Language:Inglês
Published: Korean Association for the Study of Intestinal Diseases 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4479738/
https://ncbi.nlm.nih.gov/pubmed/26130998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2015.13.3.233
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items